Compared with the control group, LGT administration significantly elevated the MDA level (P<0.01) (Figure 3A), and reduced GSH, GST, GPx, SOD, and CAT levels (all P<0.01) (Figure 3B–F) in hepatic of S180 tumor-bearing mice. This evidence concerns the gene SOD1 and neoplasm.